Ascend Capital Decreased Its Incyte (INCY) Position; Radius Health (RDUS) Has 1.42 Sentiment

November 15, 2017 - By Darrin Black

Radius Health, Inc. is a biopharmaceutical company. The company has market cap of $1.17 billion. The Firm is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. It currently has negative earnings. The Company’s lead investigational product candidate, TYMLOS injection is developed for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Ascend Capital Llc decreased Incyte Corp (INCY) stake by 38.46% reported in 2017Q2 SEC filing. Ascend Capital Llc sold 36,399 shares as Incyte Corp (INCY)’s stock rose 9.08%. The Ascend Capital Llc holds 58,242 shares with $7.33 million value, down from 94,641 last quarter. Incyte Corp now has $22.13 billion valuation. The stock declined 0.23% or $0.24 reaching $104.88 per share. About 18,943 shares traded. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since November 15, 2016 and is uptrending. It has outperformed by 56.14% the S&P500.

Mpm Asset Management Llc holds 76.39% of its portfolio in Radius Health Inc for 3.89 million shares. Bb Biotech Ag owns 5.04 million shares or 6.97% of their US portfolio. Moreover, Ra Capital Management Llc has 2.58% invested in the company for 497,157 shares. The Maryland-based Rock Springs Capital Management Lp has invested 2.08% in the stock. Farallon Capital Management Llc, a California-based fund reported 3.69 million shares.

Analysts await Radius Health Inc (NASDAQ:RDUS) to report earnings on February, 22. They expect $-1.40 EPS, down 14.75% or $0.18 from last year’s $-1.22 per share. After $-1.31 actual EPS reported by Radius Health Inc for the previous quarter, Wall Street now forecasts 6.87% negative EPS growth.

Since January 1, 0001, it had 2 buys, and 0 selling transactions for $2.82 million activity.

About 30 shares traded. Radius Health Inc (RDUS) has risen 9.02% since November 15, 2016 and is uptrending. It has underperformed by 7.68% the S&P500.

Ascend Capital Llc increased Tech Data Corp (NASDAQ:TECD) stake by 81,548 shares to 152,160 valued at $15.37 million in 2017Q2. It also upped Yum Brands Inc (NYSE:YUM) stake by 6,291 shares and now owns 32,309 shares. Boyd Gaming Corp (NYSE:BYD) was raised too.

Since May 31, 2017, it had 1 insider buy, and 3 sales for $2.52 million activity. GRYSKA DAVID W also sold $1.95 million worth of Incyte Corporation (NASDAQ:INCY) on Monday, June 12. 500 shares valued at $65,900 were bought by BIENAIME JEAN JACQUES on Wednesday, May 31. The insider Siegel Eric H. sold $236,600. 3,000 shares valued at $397,500 were sold by Trower Paul on Monday, June 5.

Analysts await Incyte Corporation (NASDAQ:INCY) to report earnings on February, 13. They expect $-0.47 earnings per share, down 413.33% or $0.62 from last year’s $0.15 per share. After $0.17 actual earnings per share reported by Incyte Corporation for the previous quarter, Wall Street now forecasts -376.47% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :